PuSH - Publication Server of Helmholtz Zentrum München: Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Rothwell, J.A.* ; Bešević, J.* ; Dimou, N.* ; Breeur, M.* ; Murphy, N.* ; Jenab, M.* ; Wedekind, R.* ; Viallon, V.* ; Ferrari, P.* ; Achaintre, D.* ; Gicquiau, A.* ; Rinaldi, S.* ; Scalbert, A.* ; Huybrechts, I.* ; Prehn, C. ; Adamski, J. ; Cross, A.J.* ; Keun, H.* ; Chadeau-Hyam, M.* ; Boutron-Ruault, M.C.* ; Overvad, K.* ; Dahm, C.C.* ; Nøst, T.H.* ; Sandanger, T.M.* ; Skeie, G.* ; Zamora-Ros, R.* ; Tsilidis, K.K.* ; Eichelmann, F.* ; Schulze, M.B.* ; van Guelpen, B.* ; Vidman, L.* ; Sánchez, M.J.* ; Amiano, P.* ; Ardanaz, E.* ; Smith-Byrne, K.* ; Travis, R.* ; Katzke, V.* ; Kaaks, R.* ; Derksen, J.W.G.* ; Colorado-Yohar, S.* ; Tumino, R.* ; Bueno-de-Mesquita, B.* ; Vineis, P.* ; Palli, D.* ; Pasanisi, F.* ; Eriksen, A.K.* ; Tjønneland, A.* ; Severi, G.* ; Gunter, M.J.*

Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts.

BMC Med. 21:80 (2023)

Publ. Version/Full Text

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

BACKGROUND: Amino acid metabolism is dysregulated in colorectal cancer patients; however, it is not clear whether pre-diagnostic levels of amino acids are associated with subsequent risk of colorectal cancer. We investigated circulating levels of amino acids in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) and UK Biobank cohorts. METHODS: Concentrations of 13-21 amino acids were determined in baseline fasting plasma or serum samples in 654 incident colorectal cancer cases and 654 matched controls in EPIC. Amino acids associated with colorectal cancer risk following adjustment for the false discovery rate (FDR) were then tested for associations in the UK Biobank, for which measurements of 9 amino acids were available in 111,323 participants, of which 1221 were incident colorectal cancer cases. RESULTS: Histidine levels were inversely associated with colorectal cancer risk in EPIC (odds ratio [OR] 0.80 per standard deviation [SD], 95% confidence interval [CI] 0.69-0.92, FDR P-value=0.03) and in UK Biobank (HR 0.93 per SD, 95% CI 0.87-0.99, P-value=0.03). Glutamine levels were borderline inversely associated with colorectal cancer risk in EPIC (OR 0.85 per SD, 95% CI 0.75-0.97, FDR P-value=0.08) and similarly in UK Biobank (HR 0.95, 95% CI 0.89-1.01, P=0.09) In both cohorts, associations changed only minimally when cases diagnosed within 2 or 5 years of follow-up were excluded. CONCLUSIONS: Higher circulating levels of histidine were associated with a lower risk of colorectal cancer in two large prospective cohorts. Further research to ascertain the role of histidine metabolism and potentially that of glutamine in colorectal cancer development is warranted.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Altmetric

9.300

0.000